Trump administration's response to the drug crisis :
Trump administration's response to the drug crisis : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, March 7, 2019.
- 1 online resource (iii, 68 pages)
"Serial no. 116-07." Access ID (govinfo): CHRG-116hhrg36619. CRDP Program record.
Hearing witnesses: James W. Carroll, Jr., Office of National Drug Control Policy; Triana McNeil, Acting Director, Strategic Issues, Government Accountability Office; Mike McDaniel, Director, Houston High Intensity Drug Trafficking Area.
Date of hearing: 2019-03-07.
36-619
United States. Office of National Drug Control Policy --Customer services.
Drug control--United States.
Opioid abuse--United States.
Opioids--Overdose--Prevention.--United States
Legislative hearings.
KF27 / .O96 2019e
1016-C (online)
Y 4.OV 2:116-07
Serial no. 116-07 (United States. Congress. House. Committee on Oversight and Reform)
"Serial no. 116-07." Access ID (govinfo): CHRG-116hhrg36619. CRDP Program record.
Hearing witnesses: James W. Carroll, Jr., Office of National Drug Control Policy; Triana McNeil, Acting Director, Strategic Issues, Government Accountability Office; Mike McDaniel, Director, Houston High Intensity Drug Trafficking Area.
Date of hearing: 2019-03-07.
36-619
United States. Office of National Drug Control Policy --Customer services.
Drug control--United States.
Opioid abuse--United States.
Opioids--Overdose--Prevention.--United States
Legislative hearings.
KF27 / .O96 2019e
1016-C (online)
Y 4.OV 2:116-07
Serial no. 116-07 (United States. Congress. House. Committee on Oversight and Reform)